Dietary modulation of immune function by β-glucans

被引:396
作者
Volman, Julia J. [1 ]
Ramakers, Julian D. [1 ]
Plat, Jogchum [1 ]
机构
[1] Maastricht Univ, Dept Human Biol, NUTRIM, NL-6200 MD Maastricht, Netherlands
关键词
dietary; beta-glucans; immune function; resistance to infections;
D O I
10.1016/j.physbeh.2007.11.045
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The immune response can be modulated by nutrients like beta-glucans, which are glucose polymers that are major structural components of the cell wall of yeast, fungi, and bacteria, but also of cereals like oat and barley. There is a lot of structural variation in the beta-glucans from these different sources, which may influence their physiological functions. In this review the current status concerning possibilities to modulate immune function by beta-glucans is discussed. In vitro as well as in vivo studies in animals and humans show that especially beta-glucans derived from fungi and yeast have immune modulating properties. Most frequently evaluated are effects on leukocyte activity, which has been suggested to contribute to the increased resistance against infections observed after p-glucan interventions. Although most studies supply the beta-glucans parenteral (e.g. intravenous or subcutaneous), also enteral administrated (dietary) beta-glucan influence the immune response. Although more human studies are needed, it is tempting to suggest that dietary beta-glucans may be a useful tool to prime the host immune system and increase resistance against invading pathogens. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 65 条
[1]  
ABBAS AK, 2003, BASIC IMMUNOLOGY FUN
[2]   STIMULATION OF HUMAN MONOCYTE BETA-GLUCAN RECEPTORS BY GLUCAN PARTICLES INDUCES PRODUCTION OF TNF-ALPHA AND IL-1-BETA [J].
ABEL, G ;
CZOP, JK .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (08) :1363-+
[3]  
ADACHI Y, 1994, BIOL PHARM BULL, V17, P1554, DOI 10.1248/bpb.17.1554
[4]   RANDOMIZED PHASE I/II TRIAL OF A MACROPHAGE-SPECIFIC IMMUNOMODULATOR (PGG-GLUCAN) IN HIGH-RISK SURGICAL PATIENTS [J].
BABINEAU, TJ ;
MARCELLO, P ;
SWAILS, W ;
KENLER, A ;
BISTRIAN, B ;
FORSE, RA .
ANNALS OF SURGERY, 1994, 220 (05) :601-609
[5]  
BABINEAU TJ, 1994, ARCH SURG-CHICAGO, V129, P1204
[6]   Ligand binding to the (1→3)-β-D-glucan receptor stimulates NFκB activation, but not apoptosis in U937 cells [J].
Battle, J ;
Ha, TZ ;
Li, CF ;
Della Beffa, V ;
Rice, P ;
Kalbfleisch, J ;
Browder, W ;
Williams, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) :499-504
[7]   Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis [J].
Bedirli, Abdulkadir ;
Kerem, Mustafa ;
Pasaoglu, Hatice ;
Akyurek, Nalan ;
Tezcaner, Tugan ;
Elbeg, Sehri ;
Memis, Leyla ;
Sakrak, Omer .
SHOCK, 2007, 27 (04) :397-401
[8]   (1->3)-beta-D-glucans as biological response modifiers: A review of structure-functional activity relationships [J].
Bohn, JA ;
BeMiller, JN .
CARBOHYDRATE POLYMERS, 1995, 28 (01) :3-14
[9]  
BROWDER W, 1990, ANN SURG, V211, P605
[10]  
BROWDER W, 1990, ANN SURG, V211, P612